| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5825308 | Clinical Therapeutics | 2015 | 14 Pages |
Abstract
This study suggests that a DD strategy is likely to be cost-saving versus empirical treatment for immunocompromised patients with persistent or recurrent neutropenic fevers.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Rosemary MD, Stephanie PhD, Raoul MD, Orla MB, BCh, Monica MB, BS, MD, Eric MSc, MD, D. Bacteriol, Cheryl McDade, Claudie MSc, PhD, David MSc, Michal MD, Haran MD, Johan MD, PhD,